Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart

被引:265
作者
Heymans, S
Schroen, B
Vermeersch, P
Milting, H
Gao, FY
Kassner, A
Gillijns, H
Herijgers, P
Flameng, W
Carmeliet, P
de Werf, FV
Pinto, YM
Janssens, S
机构
[1] Univ Maastricht, Expt & Mol Cardiol CARIM, Maastricht, Netherlands
[2] Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, Louvain, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Cardiovasc Surg, B-3000 Louvain, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Cardiol, B-3000 Louvain, Belgium
[5] Ruhr Univ Bochum, Univ Klin, Herz & Diabeteszentrum NRW, Erich & Hanna Klessmann Inst Kardiovaskulare Fors, Bad Oeynhausen, Germany
关键词
metalloproteinases; remodeling; hypertrophy; hypertension; collagen;
D O I
10.1161/CIRCULATIONAHA.104.516963
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Alterations in the balance of matrix metalloproteinases ( MMPs) and their specific tissue inhibitors (TIMPs) are involved in left ventricular (LV) remodeling. Whether their expression is related to interstitial fibrosis or LV dysfunction in patients with chronic pressure overload - induced LV hypertrophy, however, is unknown. Methods and Results - Therefore, cardiac biopsies were taken in 36 patients with isolated aortic stenosis ( AS) and in 29 control patients without LV hypertrophy. Microarray analysis revealed significantly increased mRNA expression of collagen types I, III, and IV and transcripts involved in collagen synthesis, including procollagen endopeptidase and lysine and proline hydroxylases, in AS compared with control patients. Collagen deposition was greater in AS than in control patients and was most pronounced in AS patients with severe diastolic dysfunction. Cardiac mRNA expression of TIMP-1 and TIMP-2 was significantly increased in AS compared with control patients ( mRNA transcript levels normalized to GAPDH: TIMP-1, 0.67 +/- 0.1 in AS versus 0.37 +/- 0.08 in control patients; TIMP-2, 9.5 +/- 2.6 in AS versus 1.6 +/- 0.4 in control patients; P < 0.05 for both) but did not differ significantly for MMP-1, -2, or -9. Cardiac TIMP-1 and - 2 transcripts were significantly related to the degree of interstitial fibrosis and proportional to diastolic dysfunction in AS patients. Conclusions - Cardiac expression of TIMP-1 and TIMP-2 is significantly increased in chronic pressure-overloaded human hearts compared with controls and is related to the degree of interstitial fibrosis.
引用
收藏
页码:1136 / 1144
页数:9
相关论文
共 31 条
  • [1] Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation
    Coker, ML
    Jolly, JR
    Joffs, C
    Etoh, T
    Holder, JR
    Bond, BR
    Spinale, FG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (02): : H543 - H551
  • [2] Matrix metalloproteinase inhibition after myocardial infarction - A new approach to prevent heart failure?
    Creemers, EEJM
    Cleutjens, JPM
    Smits, JFM
    Daemen, MJAP
    [J]. CIRCULATION RESEARCH, 2001, 89 (03) : 201 - 210
  • [3] Effect of propranolol on cardiac cytokine expression after myocardial infarction in rats
    Deten, A
    Volz, HC
    Holzl, A
    Briest, W
    Zimmer, HG
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 251 (1-2) : 127 - 137
  • [4] Progression from compensated hypertrophy to failure in the pressure-overloaded human heart -: Structural deterioration and compensatory mechanisms
    Hein, S
    Arnon, E
    Kostin, S
    Schönburg, M
    Elsässer, A
    Polyakova, V
    Bauer, EP
    Klövekorn, WP
    Schaper, J
    [J]. CIRCULATION, 2003, 107 (07) : 984 - 991
  • [5] Endothelial activation through brain death?
    Herijgers, P
    Nishimura, Y
    Flameng, W
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (09) : S234 - S239
  • [6] HESS OM, 1993, CIRCULATION, V87, P73
  • [7] Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice
    Heymans, S
    Lupu, F
    Terclavers, S
    Vanwetswinkel, B
    Herbert, JM
    Baker, A
    Collen, D
    Carmeliet, P
    Moons, L
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (01) : 15 - 25
  • [8] Matrix metalloproteinases and coronary artery diseases
    Ikeda, U
    Shimada, K
    [J]. CLINICAL CARDIOLOGY, 2003, 26 (02) : 55 - 59
  • [9] The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling
    Janicki, JS
    Brower, GL
    Gardner, JD
    Chancey, AL
    Stewart, JA
    [J]. HEART FAILURE REVIEWS, 2004, 9 (01) : 33 - 42
  • [10] John Ranjit, 2004, Semin Thorac Cardiovasc Surg, V16, P364